Colitis and docetaxel-based chemotherapy.
Kreis
W
W
Petrylak
D
D
Savarese
D
D
Budman
D
D
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003092:Colitis / Q000139:chemically induced*; D003967:Diarrhea / Q000139:chemically induced*; D000077143:Docetaxel; D004961:Estramustine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D004961:Estramustine; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine